![Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction](https://www.spandidos-publications.com/article_images/etm/14/5/etm-14-05-4942-g01.jpg)
Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
![Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/759b64df-e353-497e-b128-f40991968c63/e468fig01.jpeg)
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_024_FP1215_T7.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2042827553/2055610270/gr1.gif)
References in Rosuvastatin: A High-Potency HMG-CoA Reductase Inhibitor - Journal of the American Pharmacists Association
![Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update - Schachter - 2005 - Fundamental & Clinical Pharmacology - Wiley Online Library Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update - Schachter - 2005 - Fundamental & Clinical Pharmacology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2b53cdbe-17c0-467b-9f8a-6c97b2067445/fcp_299_f1.gif)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update - Schachter - 2005 - Fundamental & Clinical Pharmacology - Wiley Online Library
Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India
![Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_021_FP1215_T2.jpg.jpg)
Therapeutic Interchange From Rosuvastatin to Atorvastatin in a Veteran Population | Federal Practitioner
![Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease - International Journal of Cardiology Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f50a3574-7ba7-4cbd-bd7f-1e2be8b3a287/gr1_lrg.jpg)